82 related articles for article (PubMed ID: 20926427)
1. Acute cardiac effects of neuregulin-1/ErbB signalling.
Rochais F; Fischmeister R
Cardiovasc Res; 2010 Dec; 88(3):393-4. PubMed ID: 20926427
[No Abstract] [Full Text] [Related]
2. Neuregulin-1beta1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes.
Brero A; Ramella R; Fitou A; Dati C; Alloatti G; Gallo MP; Levi R
Cardiovasc Res; 2010 Dec; 88(3):443-52. PubMed ID: 20634213
[TBL] [Abstract][Full Text] [Related]
3. NO way to relax: the complexities of coupling nitric oxide synthase pathways in the heart.
Michel T
Circulation; 2010 Feb; 121(4):484-6. PubMed ID: 20083685
[No Abstract] [Full Text] [Related]
4. Calcium- and phosphatidylinositol 3-kinase/Akt-dependent activation of endothelial nitric oxide synthase by apigenin.
Chen CC; Ke WH; Ceng LH; Hsieh CW; Wung BS
Life Sci; 2010 Dec; 87(23-26):743-9. PubMed ID: 21034748
[TBL] [Abstract][Full Text] [Related]
5. Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway.
Tsutsumi YM; Tsutsumi R; Mawatari K; Nakaya Y; Kinoshita M; Tanaka K; Oshita S
Life Sci; 2011 Apr; 88(15-16):725-9. PubMed ID: 21338613
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.
Xu Y; Li X; Zhou M
Curr Opin Pharmacol; 2009 Apr; 9(2):214-9. PubMed ID: 19070544
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cardiac hypertrophy by intracellular signalling pathways.
Heineke J; Molkentin JD
Nat Rev Mol Cell Biol; 2006 Aug; 7(8):589-600. PubMed ID: 16936699
[TBL] [Abstract][Full Text] [Related]
8. [Neuregulin1/ErbB system: importance in the control of cardiovascular function].
Lopes-Conceição L; Dias-Neto M; Fontes-Sousa AP; Mendes-Ferreira P; Maia-Rocha C; Henriques-Coelho T; de Keulenaer G; Leite Moreira AF; Brás-Silva C
Acta Med Port; 2011 Dec; 24 Suppl 4():1009-20. PubMed ID: 22863512
[TBL] [Abstract][Full Text] [Related]
9. Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.
Nakaoka Y; Nishida K; Narimatsu M; Kamiya A; Minami T; Sawa H; Okawa K; Fujio Y; Koyama T; Maeda M; Sone M; Yamasaki S; Arai Y; Koh GY; Kodama T; Hirota H; Otsu K; Hirano T; Mochizuki N
J Clin Invest; 2007 Jul; 117(7):1771-81. PubMed ID: 17571162
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.
Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J
J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908
[TBL] [Abstract][Full Text] [Related]
11. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
Davidson SM; Hausenloy D; Duchen MR; Yellon DM
Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
[TBL] [Abstract][Full Text] [Related]
12. Paving new paths for neuregulin-1-assisted cardiac regenerative medicine. Focus on "Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA".
Lemmens K; De Keulenaer GW
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C16-7. PubMed ID: 21543744
[No Abstract] [Full Text] [Related]
13. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes.
Timolati F; Ott D; Pentassuglia L; Giraud MN; Perriard JC; Suter TM; Zuppinger C
J Mol Cell Cardiol; 2006 Nov; 41(5):845-54. PubMed ID: 17005195
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling.
Raphael J; Gozal Y; Navot N; Zuo Z
J Cardiovasc Pharmacol; 2010 Apr; 55(4):348-57. PubMed ID: 20125034
[TBL] [Abstract][Full Text] [Related]
15. Suppression of spontaneous calcium release events by nitric oxide in rat ventricular myocytes.
Mészáros LG
J Muscle Res Cell Motil; 2004; 25(8):604-5. PubMed ID: 16118854
[No Abstract] [Full Text] [Related]
16. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
[TBL] [Abstract][Full Text] [Related]
18. Palmitic and linoleic acids impair endothelial progenitor cells by inhibition of Akt/eNOS pathway.
Guo WX; Yang QD; Liu YH; Xie XY; Wang-Miao ; Niu RC
Arch Med Res; 2008 May; 39(4):434-42. PubMed ID: 18375256
[TBL] [Abstract][Full Text] [Related]
19. Tannin 1-alpha-O-galloylpunicalagin induces the calcium-dependent activation of endothelial nitric-oxide synthase via the phosphatidylinositol 3-kinase/Akt pathway in endothelial cells.
Chen LG; Liu YC; Hsieh CW; Liao BC; Wung BS
Mol Nutr Food Res; 2008 Oct; 52(10):1162-71. PubMed ID: 18435486
[TBL] [Abstract][Full Text] [Related]
20. A cordial affair - erythropoietin and cardioprotection.
Fandrey J
Cardiovasc Res; 2006 Oct; 72(1):1-2. PubMed ID: 16934784
[No Abstract] [Full Text] [Related]
[Next] [New Search]